← FDA DRUG APPROVALS

FDA ANDA · ANDA220314

SEMAGLUTIDE

Sponsor: APOTEX INC

APPLICATION
ANDA220314
TYPE
ANDA
ROUTE
SOLUTION
DOSAGE FORM
INJECTION
MARKETING STATUS
None (Tentative Approval)

Products

SEMAGLUTIDENone (Tentative Approval)
SEMAGLUTIDE 8MG/3ML · INJECTION · SOLUTION
SEMAGLUTIDENone (Tentative Approval)
SEMAGLUTIDE 2MG/3ML · INJECTION · SOLUTION
SEMAGLUTIDENone (Tentative Approval)
SEMAGLUTIDE 4MG/3ML · INJECTION · SOLUTION

Approval history

2026-04-07UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →